NM_153717.3:c.1694delC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_153717.3(EVC):c.1694delC(p.Ala565ValfsTer23) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_153717.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251446Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135890
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461726Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727154
GnomAD4 genome AF: 0.000112 AC: 17AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74312
ClinVar
Submissions by phenotype
Ellis-van Creveld syndrome Pathogenic:2
- -
- -
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ala565Valfs*23) in the EVC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). This variant is present in population databases (rs753014919, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with Ellis-van Creveld syndrome (PMID: 17024374, 23220543). ClinVar contains an entry for this variant (Variation ID: 551227). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at